Sector Processa Pharmaceuticals, Inc.

Aandelen

PCSA

US74275C4033

Biotechnologie & Medisch Onderzoek

Beurs gesloten - 22:00:00 23-10-2026 Variatie 5 dagen Verschil t.o.v. 1 jan (%)
1,810 USD -2,69% Intraday-grafiek van Processa Pharmaceuticals, Inc. +7,10% -37,15%
Belangrijkste concurrenten
Verschil (%) Varia. 5d. Evolutie 1 maand Evolutie 3 maanden Var. 1 jan Varia. 1j. Varia. 3j. Varia. 5j. Varia. 10j. Kap.($)
-2,69%+7,10%-2,16%-30,38%-37,15%-76,66%-98,90%-99,95% - 6,07 mln.
+2,41%+0,29%-10,89%+15,78%+59,66%+39,41%+72,14%+3,53% - 64,69 mld.
-0,15%+7,50%-6,30%-2,76%+9,12%+11,42%+71,27%+213,38%+5.396,84% 54,78 mld.
+0,57%+4,60%+10,84%+15,29%+17,48%+7,71%+90,93%-16,32%+249,64% 53,49 mld.
+0,37%+4,67%+1,58%+34,28%+23,93%+26,68%+49,64%+8,75%+274,78% 45,98 mld.
-1,21%+2,32%+4,91%+15,87%+24,30%+21,50%+118,33%-0,33%+1.039,50% 42,94 mld.
-0,37%+5,07%-6,44%-1,18%+134,76%+243,23%+789,58%+584,95% - 40,08 mld.
+0,05%+0,21%+9,58%+9,46%+12,77%+18,06%+48,50%+7,72%+165,49% 33,52 mld.
+1,19%-4,98%-11,75%+17,14%+45,67%+26,31%-0,76%-59,58% - 23,97 mld.
-0,38%+5,68%+16,58%+40,75%+30,44%+38,39%+28,35%-11,60%+131,12% 23,67 mld.
-1,73%+0,46%-11,23%-1,36%-7,44%-16,61%-8,02%-68,34% - 22,13 mld.
-1,76%-2,99%-23,17%-12,65%-46,34%-41,51%+272,81%+240,22%+563,75% 20,39 mld.
+2,33%+8,20%+7,83%+11,28%+19,15%+10,57%+145,78%+257,78%+2.052,44% 18,72 mld.
+1,68%+15,07%+17,30%+52,43%+73,14%+75,28%+88,06%-17,89%+317,01% 16,49 mld.
+1,73%+8,23%+8,98%+27,56%+35,74%+34,62%+81,18%-17,69%+97,83% 16,47 mld.
-1,19%+3,70%+11,35%+16,54%+47,23%+66,66%+229,07%+201,54%+471,57% 15,99 mld.
+0,16%+8,04%+5,49%-4,13% - - - - - 15,98 mld.
-1,28%-6,83%+0,43%+2,20%+173,78%+155,82%+340,73%+1.403,12%+760,22% 14,75 mld.
-0,09%+8,87%+6,54%+11,77%+1,67%+4,02%-21,66%-33,24%+117,86% 14,29 mld.
+2,81%+1,86%-1,20%-10,43%+17,39%+5,21%+539,00% - - 14,03 mld.
Gemiddelde +0,12%+3,58%+1,41%+10,37%+33,44%+34,22%+149,26%+144,23%+895,23% 27,62 mld.
Gewogen gemiddelde per kap. +0,32%+3,15%+0,36%+12,82%+36,75%+40,86%+152,07%+123,48%+1.217,01%
  1. Beurs
  2. Aandelen
  3. Koers PCSA
  4. Sector Processa Pharmaceuticals, Inc.